| Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder D Demontis, RK Walters, J Martin, M Mattheisen, TD Als, E Agerbo, ... Nature genetics 51 (1), 63-75, 2019 | 1824 | 2019 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1230 | 2018 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 912 | 2019 |
| Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis M Hoogman, J Bralten, DP Hibar, M Mennes, MP Zwiers, LSJ Schweren, ... The Lancet Psychiatry 4 (4), 310-319, 2017 | 831 | 2017 |
| Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan B Franke, G Michelini, P Asherson, T Banaschewski, A Bilbow, ... European Neuropsychopharmacology 28 (10), 1059-1088, 2018 | 537 | 2018 |
| The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder SV Faraone, T Banaschewski, D Coghill, Y Zheng, J Biederman, ... Neuroscience & Biobehavioral Reviews 128, 789-818, 2021 | 528 | 2021 |
| The genetics of attention deficit/hyperactivity disorder in adults, a review B Franke, SV Faraone, P Asherson, J Buitelaar, CHD Bau, ... Molecular psychiatry 17 (10), 960-987, 2012 | 525 | 2012 |
| Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients A Halmøy, OB Fasmer, C Gillberg, J Haavik Journal of attention disorders 13 (2), 175-187, 2009 | 380 | 2009 |
| A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication M Arcos-Burgos, M Jain, MT Acosta, S Shively, H Stanescu, D Wallis, ... Molecular psychiatry 15 (11), 1053-1066, 2010 | 326 | 2010 |
| Tyrosine hydroxylase and Parkinson's disease J Haavik, K Toska Molecular neurobiology 16, 285-309, 1998 | 294 | 1998 |
| Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples M Hoogman, R Muetzel, JP Guimaraes, E Shumskaya, M Mennes, ... American Journal of Psychiatry 176 (7), 531-542, 2019 | 292 | 2019 |
| Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium XZ Kong, SR Mathias, T Guadalupe, ENIGMA Laterality Working Group, ... Proceedings of the National Academy of Sciences 115 (22), E5154-E5163, 2018 | 292 | 2018 |
| Pre-and perinatal risk factors in adults with attention-deficit/hyperactivity disorder A Halmøy, K Klungsøyr, R Skjærven, J Haavik Biological psychiatry 71 (5), 474-481, 2012 | 244 | 2012 |
| Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases BE Oftedal, A Hellesen, MM Erichsen, E Bratland, A Vardi, J Perheentupa, ... Immunity 42 (6), 1185-1196, 2015 | 231 | 2015 |
| Three-Dimensional Structure of Human Tryptophan Hydroxylase and Its Implications for the Biosynthesis of the Neurotransmitters Serotonin and Melatonin, L Wang, H Erlandsen, J Haavik, PM Knappskog, RC Stevens Biochemistry 41 (42), 12569-12574, 2002 | 231 | 2002 |
| Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD B Franke, AA Vasquez, S Johansson, M Hoogman, J Romanos, ... Neuropsychopharmacology 35 (3), 656-664, 2010 | 228 | 2010 |
| Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen‐activated protein (MAP) kinase and MAP‐kinase‐activated kinases 1 and 2 C Sutherland, J Alterio, DG Campbell, B Le Bourdellès, J Mallet, J Haavik, ... European journal of biochemistry 217 (2), 715-722, 1993 | 210 | 1993 |
| Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies M Fredriksen, A Halmøy, SV Faraone, J Haavik European Neuropsychopharmacology 23 (6), 508-527, 2013 | 207 | 2013 |
| Identification of tryptophan hydroxylase as an intestinal autoantigen O Ekwall, H Hedstrand, L Grimelius, J Haavik, J Perheentupa, ... The Lancet 352 (9124), 279-283, 1998 | 201 | 1998 |
| Different properties of the central and peripheral forms of human tryptophan hydroxylase J McKinney, PM Knappskog, J Haavik Journal of neurochemistry 92 (2), 311-320, 2005 | 197 | 2005 |
Aurora MartinezProfessor ved University of BergenVerified email at uib.no
